{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:57:40Z","timestamp":1789095460480,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical University","doi-asserted-by":"publisher","award":["2023byzd020"],"award-info":[{"award-number":["2023byzd020"]}],"id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.intimp.2025.115019","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:30:30Z","timestamp":1749699030000},"page":"115019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Self-assembled ferritin nanoparticles using SpyCatcher\/SpyTag multimerization of Mycobacterium tuberculosis TB10.4 protein induce potent immunogenicity"],"prefix":"10.1016","volume":"161","author":[{"given":"Fangzheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Xiesihan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hairui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9372-0386","authenticated-orcid":false,"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115019_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-med-100622-024848","article-title":"More tailored approaches to tuberculosis treatment and prevention","volume":"75","author":"Bark","year":"2024","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0010","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S1473-3099(21)00403-5","article-title":"100 years of Mycobacterium bovis bacille Calmette-Gu\u00e9rin","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"9493","key":"10.1016\/j.intimp.2025.115019_bb0015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/S0140-6736(05)67145-0","article-title":"Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial","volume":"366","author":"Rodrigues","year":"2005","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.intimp.2025.115019_bb0020","first-page":"717","article-title":"Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong","volume":"5","author":"Leung","year":"2001","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115019_bb0025","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1016\/S2213-2600(24)00009-2","article-title":"What is next for BCG revaccination to prevent tuberculosis?","volume":"12","author":"White","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.intimp.2025.115019_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jconrel.2024.01.017","article-title":"Protein subunit vaccines: promising frontiers against COVID-19","volume":"366","author":"Chavda","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.intimp.2025.115019_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003734","article-title":"Mycobacterium tuberculosis type VII secreted effector EsxH targets host ESCRT to impair trafficking","volume":"9","author":"Mehra","year":"2013","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.intimp.2025.115019_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01073-14","article-title":"Mycobacterial Esx-3 requires multiple components for iron acquisition","volume":"5","author":"Siegrist","year":"2014","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0045","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.68.1.214-220.2000","article-title":"Comparative evaluation of low-molecular-mass proteins from mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens","volume":"68","author":"Skj\u00f8t","year":"2000","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.intimp.2025.115019_bb0050","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41392-023-01408-5","article-title":"Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115019_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijid.2020.05.117","article-title":"Disseminated BACILLUS-CALMETTE-GU\u00c9RIN infections and primary immunodeficiency disorders in SINGAPORE: a single CENTER 15-year retrospective review","volume":"97","author":"Ong","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115019_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114020","article-title":"Delivery of STING agonists for adjuvanting subunit vaccines","volume":"179","author":"Van Herck","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12951-023-02210-9","article-title":"A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response","volume":"21","author":"Song","year":"2023","journal-title":"J Nanobiotechnol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115019_bb0075","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.apsb.2021.12.021","article-title":"Emerging vaccine nanotechnology: from defense against infection to sniping cancer","volume":"12","author":"Feng","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"14","key":"10.1016\/j.intimp.2025.115019_bb0080","doi-asserted-by":"crossref","first-page":"13474","DOI":"10.1021\/acsnano.3c01829","article-title":"An intranasal multivalent epitope-based nanoparticle vaccine confers broad protection against divergent influenza viruses","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.115019_bb0085","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41565-020-0648-y","article-title":"Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B","volume":"15","author":"Wang","year":"2020","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0090","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s11658-024-00585-7","article-title":"Analysis of the components of mycobacterium tuberculosis heat-resistant antigen (Mtb-HAg) and its regulation of \u03b3\u03b4 T-cell function","volume":"29","author":"Wei","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.intimp.2025.115019_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156610","article-title":"Immune responses induced by mycobacterium tuberculosis heat-resistant antigen (Mtb-HAg) upon co-administration with Bacillus Calmette-Gu\u00e9rin in mice","volume":"179","author":"Guo","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2025.115019_bb0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-1-0716-3754-8_17","article-title":"Assessing antigen-specific T cell responses through IFN-\u03b3 enzyme-linked immune absorbent spot (ELISpot)","volume":"2782","author":"Freen-van Heeren","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.intimp.2025.115019_bb0105","article-title":"Impacts of MDR\/XDR-TB on the global tuberculosis epidemic: challenges and opportunities","volume":"7","author":"Chin","year":"2024","journal-title":"Curr Res Microb Sci."},{"issue":"4","key":"10.1016\/j.intimp.2025.115019_bb0110","article-title":"Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate","volume":"3","author":"Zhuang","year":"2024","journal-title":"Infect Med (Beijing)."},{"issue":"6","key":"10.1016\/j.intimp.2025.115019_bb0115","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/JCM.00648-11","article-title":"Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates","volume":"49","author":"Kolibab","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115019_bb0120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2025.115019_bb0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ijbiomac.2022.10.126","article-title":"Ferritin self-assembly, structure, function, and biotechnological applications","volume":"224","author":"Sudarev","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.intimp.2025.115019_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125597","article-title":"Self-assembling protein nanoparticle platform for multivalent antigen delivery in vaccine development","volume":"676","author":"Wu","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.intimp.2025.115019_bb0135","doi-asserted-by":"crossref","first-page":"1216364","DOI":"10.3389\/fcimb.2023.1216364","article-title":"SpyTag\/SpyCatcher display of influenza M2e peptide on norovirus-like particle provides stronger immunization than direct genetic fusion","volume":"13","author":"Lampinen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115019_bb0140","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged Nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2025.115019_bb0145","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nano.2018.11.009","article-title":"Ferritin nanoparticle-based SpyTag\/SpyCatcher-enabled click vaccine for tumor immunotherapy","volume":"16","author":"Wang","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.intimp.2025.115019_bb0150","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12951-016-0181-1","article-title":"Bacterial superglue enables easy development of efficient virus-like particle based vaccines","volume":"14","author":"Thrane","year":"2016","journal-title":"J Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115019_bb0155","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02277-24","article-title":"Protease shaving of mycobacterium tuberculosis facilitates vaccine antigen discovery and delivery of novel cargoes to the Mtb surface","volume":"13","author":"Lepe","year":"2025","journal-title":"Microbiol Spectr."},{"issue":"8","key":"10.1016\/j.intimp.2025.115019_bb0160","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.02567-17","article-title":"Display of recombinant proteins on bacterial outer membrane vesicles by using protein ligation","volume":"84","author":"Van Den Berg Van Saparoea","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115019_bb0165","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s41423-020-0502-z","article-title":"New insights into the evasion of host innate immunity by mycobacterium tuberculosis","volume":"17","author":"Chai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2025.115019_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127153","article-title":"Host-mycobacteria conflict: immune responses of the host vs. the mycobacteria TLR2 and TLR4 ligands and concomitant host-directed therapy","volume":"264","author":"Pattanaik","year":"2022","journal-title":"Microbiol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115019_bb0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.icb.7100027","article-title":"Life and death in the granuloma: immunopathology of tuberculosis","volume":"85","author":"Saunders","year":"2007","journal-title":"Immunol. Cell Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115019_bb0180","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1359-6101(03)00054-6","article-title":"Chemokines and tuberculosis","volume":"14","author":"Algood","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2025.115019_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ebiom.2017.08.001","article-title":"IL-17 production of neutrophils enhances Antibacteria ability but promotes arthritis development during mycobacterium tuberculosis infection","volume":"23","author":"Hu","year":"2017","journal-title":"EBioMedicine"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925010094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:51:11Z","timestamp":1775764271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925010094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":37,"alternative-id":["S1567576925010094"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115019","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Self-assembled ferritin nanoparticles using SpyCatcher\/SpyTag multimerization of Mycobacterium tuberculosis TB10.4 protein induce potent immunogenicity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115019"}}